文献速递主动脉疾病

腹主动脉瘤腔内修复术后15年多中心登记研究:长期无动脉瘤相关死亡结果良好

Long-term freedom from aneurysm-related mortality remains favorable after endovascular abdominal aortic aneurysm repair in a 15-year multicenter registry.
PubMed 文献 · J Vasc Surg · 2019-09-05

该多中心登记研究纳入2000至2010年间接受EVAR的1736例AAA患者,随访延长至2015年。结果显示总体无动脉瘤相关死亡(ARM)粗率为96.4%,延迟破裂率1.3%,主要不良事件或再干预豁免率为84.0%。女性、80-89岁、急诊EVAR及任何主要再干预是ARM的显著预测因素。

要点

  • EVAR术后长期无ARM结果良好,延迟破裂率极低。
  • 女性、高龄、急诊EVAR及主要再干预与ARM风险显著相关。
  • 晚期组5年全因生存率显著高于早期组,但5年无ARM率无显著差异。

核心结论

  • EVAR术后长期无主要不良事件或主要再干预结果良好,ARM和延迟破裂率极低。
  • EVAR可作为AAA患者安全的长期治疗方案。

研究设计与样本

  • 多中心登记研究,纳入2000至2010年间接受EVAR的1736例AAA患者,随访延长至2015年。
  • 比较早期(2000-2005)和晚期(2006-2010)入组患者的结局。

主要发现

  • 总体随访率96.3%,中位随访5.5年(IQR 2.8-7.7年)。
  • 958例死亡中63例(6.6%)发生ARM,总体无ARM粗率96.4%。
  • 延迟破裂发生率1.3%(n=23),中位至事件时间4.1年(IQR 1.7-7.2年)。
  • 主要不良事件发生率12.4%,主要再干预率10.3%,无主要不良事件或主要再干预总体率84.0%。
  • ARM显著预测因素包括女性、80-89岁、急诊EVAR及任何主要再干预。

临床怎么用

  • 支持EVAR作为AAA的长期安全治疗选择。
  • 可根据女性、高龄、急诊EVAR及再干预等参数分层制定术后监测和再干预需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular aneurysm repair (EVAR) has become the preferred approach to abdominal aortic aneurysm (AAA) because of lower early morbidity and mortality than open repair. However, the ability of EVAR to prevent long-term aneurysm-related mortality (ARM) has been questioned in light of recent trial data. We have updated our long-term EVAR experience in a large multicenter registry to further examine this issue. METHODS: Between 2000 and 2010, 1736 patients with AAA underwent EVAR in a large integrated regional healthcare system. We extended follow-up in this previously reported cohort through 2015 and identified predictors associated with ARM and need for major reintervention. The primary outcome was ARM. Secondary outcomes were all-cause mortality, delayed aneurysm rupture, major adverse event, major reintervention, sac growth of more than 5 mm, and type I or III endoleak. End points were analyzed for the whole cohort and compared for patients who underwent EVAR during the earlier (2000-2005) and latter (2006-2010) halves of the enrollment period to assess for changes in outcomes over time of repair. RESULTS: The overall follow-up rate was 96.3%, and median follow-up was 5.5 years (interquartile range, 2.8-7.7 years). During the study period, 958 patients died, of whom 63 experienced ARM (6.6%). Overall crude rate of freedom from ARM was 96.4%. Delayed aneurysm rupture was seen in 1.3% (n = 23), with a median time to event of 4.1 years (interquartile range, 1.7-7.2 years). Major adverse events occurred in 12.4% of patients, and major reintervention was performed in 10.3%. Overall freedom from major adverse event or major reintervention was seen in 84.0%. Significant predictors of ARM included female sex, age 80 to 89 years, urgent EVAR, and any major reintervention. The unadjusted cumulative probability of all-cause survival was significantly higher in the late group than the early group at 5 years (66.8% vs 59.8%; P = .01, log-rank test); however, freedom from ARM at 5 years was not significantly different (96.5% and 97.1%, respectively; P = .67, log-rank test). CONCLUSIONS: Our results demonstrate favorable long-term freedom from major adverse event or major reintervention after EVAR and extremely low rates of ARM and delayed rupture. Our findings support EVAR as a safe, long-term solution for managing patients with AAA and provide insight into clinical parameters that can be used to stratify patients' post-EVAR surveillance and need for reintervention.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rich N, Tucker LY, Okuhn S, et al. Long-term freedom from aneurysm-related mortality remains favorable after endovascular abdominal aortic aneurysm repair in a 15-year multicenter registry. J Vasc Surg. 2019. PMID: 31495678. doi:10.1016/j.jvs.2019.05.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。